References
- Aarsland, D., Brønnick, K., Larsen, J. P., Tysnes, O. B., & Alves, G, Norwegian ParkWest Study Group (2009). Cognitive impairment in incident, untreated Parkinson disease: The Norwegian ParkWest study. Neurology, 72(13), 1121–1126. https://doi.org/https://doi.org/10.1212/01.wnl.0000338632.00552.cb.
- Aarsland, D., Bronnick, K., Williams-Gray, C., Weintraub, D., Marder, K., Kulisevs.ky, J., Burn, D., Barone, P., Pagonabarraga, J., Allcock, L., Santangelo, G., Foltynie, T., Janvin, C., Larsen, J. P., Barker, R. A., & Emre, M. (2010). Mild cognitive impairment in Parkinson disease: A multicenter pooled analysis. Neurology, 75(12), 1062–1069. https://doi.org/https://doi.org/10.1212/WNL.0b013e3181f39d0e.
- Aarsland, D., & Kurz, M. W. (2010). The epidemiology of dementia associated with Parkinson disease. Journal of the Neurological Sciences, 289(1–2), 18–22. https://doi.org/https://doi.org/10.1016/j.jns.2009.08.034.
- Aretouli, E., & Kosmidis, M. H. (2007). May). Rey–Osterrieth Complex Figure Test: Greek norms and cultural and demographic influences [Poster presentation]. The 9th European Conference on Psychological Assessment & the 2nd International Conference of the Psychological Society of Northern Greece, Thessaloniki, Greece.
- Biundo, R., Weis, L., & Antonini, A. (2016). Cognitive decline in Parkinson’s disease: The complex picture. NPJ Parkinson's Disease, 2(1), 1–7. https://doi.org/https://doi.org/10.1038/npjparkd.2016.18.
- Bohnen, N. I., & Albin, R. L. (2011). The cholinergic system and Parkinson disease. Behavioural Brain Research, 221(2), 564–573. https://doi.org/https://doi.org/10.1016/j.bbr.2009.12.048.
- Ceravolo, R., Pagni, C., Tognoni, G., & Bonuccelli, U. (2012). The epidemiology and clinical manifestations of dysexecutive syndrome in Parkinson's disease. Frontiers in Neurology, 3, 159. https://doi.org/https://doi.org/10.3389/fneur.2012.00159.
- Cholerton, B. A., Zabetian, C. P., Wan, J. Y., Montine, T. J., Quinn, J. F., Mata, I. F., Chung, K. A., Peterson, A., Espay, A. J., Revilla, F. J., Devoto, J., Watson, G. S., Hu, S.-C., Leverenz, J. B., & Edwards, K. L. (2014). Evaluation of mild cognitive impairment subtypes in Parkinson's disease. Movement Disorders, 29(6), 756–764. https://doi.org/https://doi.org/10.1002/mds.25875.
- Davie, C. A. (2008). A review of Parkinson's disease. British Medical Bulletin, 86(1), 109–127. https://doi.org/https://doi.org/10.1093/bmb/ldn013.
- Duff, K., Schoenberg, M. R., Scott, J. G., & Adams, R. L. (2005). The relationship between executive functioning and verbal and visual learning and memory. Archives of Clinical Neuropsychology, 20(1), 111–122. https://doi.org/https://doi.org/10.1016/j.acn.2004.03.003
- Gauthier, S., Reisberg, B., Zaudig, M., Petersen, R. C., Ritchie, K., Broich, K., Belleville, S., Brodaty, H., Bennett, D., Chertkow, H., Cummings, J. L., de Leon, M., Feldman, H., Ganguli, M., Hampel, H., Scheltens, P., Tierney, M. C., Whitehouse, P., & Winblad, B. (2006). Mild cognitive impairment. The Lancet, 367(9518), 1262–1270. https://doi.org/https://doi.org/10.1016/S0140-6736(06)68542-5.
- Goetz, C. G., Poewe, W., Rascol, O., Sampaio, C., Stebbins, G. T., Counsell, C., Giladi, N., Holloway, R. G., Moore, C. G., Wenning, G. K., Yahr, M. D., & Seidl, L., Movement Disorder Society Task Force on Rating Scales for Parkinson's Disease (2004). Movement disorder society task force report on the Hoehn and Yahr staging scale: Status and recommendations the Movement Disorder Society Task Force on rating scales for Parkinson's disease. Movement Disorders, 19(9), 1020–1028. doi: https://doi.org/https://doi.org/10.1002/mds.20213.
- Irwin, D. J., Lee, V. M. Y., & Trojanowski, J. Q. (2013). Parkinson's disease dementia: Convergence of α-synuclein, tau and amyloid-β pathologies. Nature Reviews. Neuroscience, 14(9), 626–636. https://doi.org/https://doi.org/10.1038/nrn3549.
- Kalbe, E., Rehberg, S. P., Heber, I., Kronenbuerger, M., Schulz, J. B., Storch, A., Linse, K., Schneider, C., Gräber, S., Liepelt-Scarfone, I., Berg, D., Dams, J., Balzer-Geldsetzer, M., Hilker, R., Oberschmidt, C., Witt, K., Schmidt, N., Mollenhauer, B., Trenkwalder, C., … Dodel, R. (2016). Subtypes of mild cognitive impairment in patients with Parkinson's disease: Evidence from the LANDSCAPE study. Journal of Neurology, Neurosurgery, and Psychiatry, 87(10), 1099–1105. https://doi.org/https://doi.org/10.1136/jnnp-2016-313838.
- Kehagia, A. A., Barker, R. A., & Robbins, T. W. (2013). Cognitive impairment in Parkinson's disease: The dual syndrome hypothesis. Neuro-Degenerative Diseases, 11(2), 79–92. https://doi.org/https://doi.org/10.1159/000341998.
- Konstantopoulos, K., Vogazianos, P., & Doskas, T. (2016). Normative data of the Montreal Cognitive Assessment in the Greek population and parkinsonian dementia. Archives of Clinical Neuropsychology, 31(3), 246–253. https://doi.org/https://doi.org/10.1093/arclin/acw002.
- Kuhl, D. E., Minoshima, S., Fessler, J. A., Frey, K. A., Foster, N. L., Ficaro, E. P., Wieland, D. M., & Koeppe, R. A. (1996). In vivo mapping of cholinergic terminals in normal aging, Alzheimer's disease, and Parkinson's disease. Annals of Neurology, 40(3), 399–410. https://doi.org/https://doi.org/10.1002/ana.410400309.
- Litvan, I., Aarsland, D., Adler, C. H., Goldman, J. G., Kulisevs.ky, J., Mollenhauer, B., Rodriguez-Oroz, M. C., Tröster, A. I., & Weintraub, D. (2011). MDS task force on mild cognitive impairment in Parkinson's disease: Critical review of PD-MCI. Movement Disorders, 26(10), 1814–1824. https://doi.org/https://doi.org/10.1002/mds.23823.
- Litvan, I., Goldman, J. G., Tröster, A. I., Schmand, B. A., Weintraub, D., Petersen, R. C., Mollenhauer, B., Adler, C. H., Marder, K., Williams-Gray, C. H., Aarsland, D., Kulisevs.ky, J., Rodriguez-Oroz, M. C., Burn, D. J., Barker, R. A., & Emre, M. (2012). Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines. Movement Disorders, 27(3), 349–356. https://doi.org/https://doi.org/10.1002/mds.24893.
- Marras, C., Armstrong, M. J., Meaney, C. A., Fox, S., Rothberg, B., Reginold, W., Tang-Wai, D. F., Gill, D., Eslinger, P. J., Zadikoff, C., Kennedy, N., Marshall, F. J., Mapstone, M., Chou, K. L., Persad, C., Litvan, I., Mast, B. T., Gerstenecker, A. T., Weintraub, S., & Duff-Canning, S. (2013). Measuring mild cognitive impairment in patients with Parkinson's disease. Movement Disorders: Official Journal of the Movement Disorder Society, 28(5), 626–633. https://doi.org/https://doi.org/10.1002/mds.25426.
- Messinis, L., Tsakona, I., Malefaki, S., & Papathanasopoulos, P. (2007). Normative data and discriminant validity of Rey's Verbal Learning Test for the Greek adult population. Archives of Clinical Neuropsychology, 22(6), 739–752. https://doi.org/https://doi.org/10.1016/j.acn.2007.06.002.
- Meyers, J., & Meyers, K. (1995). The Meyers Scoring System for the rey complex figure and the recognition trial: Professional manual. Psychological Assessment Resources.
- Müller, M. L., & Bohnen, N. I. (2013). Cholinergic dysfunction in Parkinson's disease. Current Neurology and Neuroscience Reports, 13(9), 377https://doi.org/https://doi.org/10.1007/s11910-013-0377-9.
- Nasreddine, Z. S., Phillips, N. A., Bédirian, V., Charbonneau, S., Whitehead, V., Collin, I., Cummings, J. L., & Chertkow, H. (2005). The Montreal Cognitive Assessment, MoCA: A brief screening tool for mild cognitive impairment. Journal of the American Geriatrics Society, 53(4), 695–699. https://doi.org/https://doi.org/10.1111/j.1532-5415.2005.53221.x.
- Ober, B. A., Jagust, W. J., Koss, E., Delis, D. C., & Friedland, R. P. (1991). Visuoconstructive performance and regional cerebral glucose metabolism in Alzheimer's disease. J Clin Exp Neuropsychol, 13(5), 752–772. https://doi.org/https://doi.org/10.1080/01688639108401088.
- Pagonabarraga, J., & Kulisevs.ky, J. (2012). Cognitive impairment and dementia in Parkinson's disease. Neurobiology of Disease, 46(3), 590–596. https://doi.org/https://doi.org/10.1016/j.nbd.2012.03.029.
- Partington, J. E., & Leiter, R. G. (1949). Partington’s pathway test. The Psychological Service Center Bulletin, 1, 9–20.
- Petersen, R. C. (2004). Mild cognitive impairment as a diagnostic entity. Journal of Internal Medicine, 256(3), 183–194. https://doi.org/https://doi.org/10.1111/j.1365-2796.2004.01388.x.
- Petersen, R. C., Smith, G. E., Waring, S. C., Ivnik, R. J., Tangalos, E. G., & Kokmen, E. (1999). Mild cognitive impairment: clinical characterization and outcome. Archives of Neurology, 56(3), 303–308. https://doi.org/https://doi.org/10.1001/archneur.56.3.303.
- Rey, A. (1941). L'examen psychologique dans les cas d'encéphalopathie traumatique. (Les problems.) [The psychological examination in cases of traumatic encepholopathy. Problems]. Archives de Psychologie, 28, 215–285.
- Schmidt, M. (1996). Rey auditory verbal learning test: A handbook. Western Psychological Services.
- Shinotoh, H., Namba, H., Yamaguchi, M., Fukushi, K., Nagatsuka, S., Iyo, M., Asahina, M., Hattori, T., Tanada, S., & Irie, T. (1999). Positron emission tomographic measurement of acetylcholinesterase activity reveals differential loss of ascending cholinergic systems in Parkinson's disease and progressive supranuclear palsy. Annals of Neurology, 46(1), 62–69. https://doi.org/https://doi.org/10.1002/1531-8249(199907)46:1<62::AID-ANA10>3.0.CO;2-P.
- Szeto, J. Y. Y., O’Callaghan, C., Shine, J. M., Walton, C. C., Mowszowski, L., Naismith, S. L., Halliday, G. M., & Lewis, S. J. (2015). The relationships between mild cognitive impairment and phenotype in Parkinson’s disease. NPJ Parkinson's Disease, 1(1), 1–7. https://doi.org/https://doi.org/10.1038/npjparkd.2015.15.
- Zalonis, I., Christidi, F., Bonakis, A., Kararizou, E., Triantafyllou, N. I., Paraskevas, G., Kapaki, E., & Vasilopoulos, D. (2009). The stroop effect in Greek healthy population: Normative data for the stroop neuropsychological screening test. Archives of Clinical Neuropsychology, 24(1), 81–88. https://doi.org/https://doi.org/10.1093/arclin/acp011.
- Zalonis, I., Kararizou, E., Triantafyllou, N. I., Kapaki, E., Papageorgiou, S., Sgouropoulos, P. E. E. A., & Vassilopoulos, D. (2008). A normative study of the trail making test A and B in Greek adults. The Clinical Neuropsychologist, 22(5), 842–850. https://doi.org/https://doi.org/10.1080/13854040701629301.